Literature DB >> 14871534

Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro.

Robyn E Gray1, Natalie Seng, Ian R Mackay, Merrill J Rowley.   

Abstract

Antibodies to type II collagen (collagen II) are pathogenic in experimental collagen-induced arthritis (CIA) and possibly also in rheumatoid arthritis (RA). Hitherto, results of assays for anti-collagen II have proven to be inconsistent. We tested whether mouse monoclonal antibodies (mAbs) to collagen II inhibit the natural self-assembly of soluble triple-stranded collagen II monomers to form insoluble polymeric fibrils. A spectrophotometric assay of self-assembly was based on change in absorbance at 313 nm, observed over 0-60 min after neutralisation and warming of a solution of monomeric collagen II. Two mAbs to collagen II (CII-CI and M2.139) strongly inhibited self-assembly of collagen II but not collagen I, whereas another antibody, CII-F4, and an irrelevant control mAb did not. Notably, CII-CI and M2.139, but not CII-F4, induce arthritis on passive transfer to naïve mice. The arthritogenic effects of mAbs CII-CI and M2.139 in vivo, and inhibition of collagen II self-assembly in vitro, may be attributable to interference with critical epitopes at sites essential for the stabilisation of the mature polymeric collagen II fibril, and, hence, the integrity of the entire cartilage matrix. This assay for inhibition of self-assembly of collagen II could be developed for routine measurement of anti-collagen II in body fluids as a marker of early RA, and perhaps also to distinguish populations of antibodies to collagen II that either have or lack the capacity to perpetuate arthritis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871534     DOI: 10.1016/j.jim.2003.11.010

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  B Cell in Autoimmune Diseases.

Authors:  Christiane S Hampe
Journal:  Scientifica (Cairo)       Date:  2012

2.  Destructive effects of murine arthritogenic antibodies to type II collagen on cartilage explants in vitro.

Authors:  Duncan E Crombie; Muhammed Turer; Beltzane Biurrun Zuasti; Bayden Wood; Don McNaughton; Kutty Selva Nandakumar; Rikard Holmdahl; Marie-Paule Van Damme; Merrill J Rowley
Journal:  Arthritis Res Ther       Date:  2005-06-06       Impact factor: 5.156

3.  Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity.

Authors:  Stefan Carlsen; Kutty Selva Nandakumar; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 4.  Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis.

Authors:  Kutty Selva Nandakumar; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

5.  Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.

Authors:  Kutty Selva Nandakumar; Johan Bäcklund; Mikael Vestberg; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2004-09-23       Impact factor: 5.156

Review 6.  Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues.

Authors:  Kutty Selva Nandakumar
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

Review 7.  Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis.

Authors:  Qinghua Fang; Jiaxin Ou; Kutty Selva Nandakumar
Journal:  Mediators Inflamm       Date:  2019-10-27       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.